Chemotherapy Doctors in test — Page 6

Dr. Elad Jacoby is a pioneer of pediatric CAR T–cell therapy in Israel. He heads the Pediatric Cell Therapy Center at Sheba Medical Center. Dr. Jacoby specializes in treating relapsed and high-risk pediatric leukemias and lymphomas. He completed fellowships at Johns Hopkins and the U.S. National Cancer Institute.

• Medical Director of the Advanced Biotherapy Center at Sheba Medical Center.
• Authored over 240 scientific publications in pediatric hemato-oncology.
• Board-certified in both Pediatrics and Pediatric Hematology and Oncology.
• Leads the integration of CAR T–cell therapy with bone marrow transplantation.

Dr. Eytan Aharon Ben-Ami leads the Oncology Division at Sheba Medical Center in Israel. He specialized in sarcoma and bone oncology at the Dana-Farber Cancer Institute. Dr. Ben-Ami founded the Sheba Clinical Research Organization to advance cancer studies. He treats rare bone tumors and soft tissue sarcomas with personalized protocols.

• Heads the Early-Phase Clinical Trials Unit for innovative cancer therapies.
• Authored over 40 scientific publications on molecular mechanisms and early detection.
• Leads Phase I trials in targeted therapy and immunotherapy for rare cancers.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Iris Kventsel is a pediatric hemato-oncologist and bone marrow transplant specialist at Sheba Medical Center. She treats childhood sarcomas like Ewing sarcoma and osteosarcoma at the Edmond and Lily Safra Children’s Hospital. Dr. Kventsel integrates targeted therapies with cellular treatments for complex childhood cancers. She serves on the academic staff at Tel Aviv University Faculty of Medicine.

• Specializes in bone marrow transplantation and CAR T-cell therapy for pediatric patients.
• Researches genetic cancer predisposition, including Li-Fraumeni syndrome and susceptibility genes.
• Published in major journals on stem cell biology and surgical oncology (HIPEC).
• Works at Sheba Medical Center, ranked among the world’s top 10 hospitals.

Radiotherapy specialist with a dedicated focus on oncology at Rambam Medical Center.

• Specializes in chemotherapy and radiotherapy treatments
• Works at Rambam Medical Center, a leading healthcare institution
• Committed to personalized cancer care plans

Dr. Hila Magen is a leading Israeli hemato-oncologist at Sheba Medical Center. She heads the Multiple Myeloma and Amyloidosis Unit. Dr. Magen specializes in treating complex plasma cell disorders and high-risk myeloma. She is a principal investigator for innovative point-of-care CAR-T therapy programs. Her work brings advanced immunotherapies into routine clinical care.

• Authored over 100 scientific publications and landmark myeloma studies.
• Completed fellowships at MD Anderson and University of Arkansas for Medical Sciences.
• Performs CAR-T cell therapy and bone marrow transplantations.
• Works at Sheba Medical Center, ranked 7th worldwide in 2026 by Newsweek.

Dr. Avichai Shimoni is the Director of Bone Marrow Transplantation at Sheba Medical Center. He treats complex blood cancers. He completed a specialized fellowship at the MD Anderson Cancer Center. Dr. Shimoni uses allogeneic and autologous transplants for high-risk patients. He is a professor and Chairman of Hematology at Tel Aviv University.

• Named among Israel’s Best Doctors by Forbes for 2025 and 2026.
• Authored over 250 scientific papers on cellular therapies and transplantation.
• Provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.

• Authored over 130 scientific publications on hemato-oncology and cellular therapy.
• Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
• Leads allogeneic and autologous bone marrow transplantation programs.
• Served as the Chairman of the Israeli Lymphoma Study Group.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Israel's leading specialist in lung cancer immunotherapy – Prof. Peled heads the Thoracic Cancer Unit at Davidoff Cancer Center.

• Fellowship-trained in lung cancer at University of Colorado Denver
• Received MERIT award from American Society of Clinical Oncology (ASCO)
• Chairs IASLC's Early Detection & Prevention Committee
• Specializes in personalized medicine and immuno-oncology for lung cancer

Specializes in breast cancer and melanoma treatments, focusing on hormone therapy resistance and immunotherapy. Works at Hospital Quiron Barcelona.

• Participated in trials leading to new drug approvals for breast cancer
• Involved in studies that revolutionized melanoma treatment
• Member of Breast Cancer and Melanoma Units at Vall d’Hebron
• Focuses on holistic patient care

Leading expert in chronic lymphocytic leukemia (CLL) – Professor Bosch has pioneered new treatments and technologies for hematological diseases.

• Conducts over 80 clinical trials from phase 1 to phase 3
• Published more than 100 articles in top medical journals
• Head of Hematology at IOB Institute of Oncology
• President of the Spanish group for CLL study (GELLC)

Principal Investigator in clinical trials for ovarian, cervical, and endometrial cancer – Dr. Oaknin leads groundbreaking research at Hospital Quiron Barcelona.

• Author of 100+ publications on gynecological tumors
• Executive board member of GEICO Group (Spanish Ovarian Cancer Research Group)
• Faculty member for Gyn-Track in ESMO
• Spanish representative in GCIG Group's Cervical Committee

Dr. Graus is a leading expert in paraneoplastic neurological syndromes, having defined the first strict diagnostic criteria for these conditions.

• 44 years of experience of experience in neuro-oncology
• Former Chief of Neurology at Hospital Clinic Barcelona
• Founder and past president of the European Association of Neuro-Oncology
• Specializes in neurotoxicities from cancer treatments
• Honorary doctorate from Lyon University

Dr. Prat leads SOLTI as president, designing clinical trials for breast cancer treatments. His research focuses on gene expression and molecular subtypes.

• Head of Translational Genomics and Targeted Therapeutics at IDIBAPS
• Co-founder of Reveal Genomics, holds three patents
• Over 160 publications with an H-Index of 51
• Medical oncology fellowship at Vall d´Hebron Institute of Oncology
• Tenure-Track Professor at Barcelona University

Specialized in gynecological oncology and chemotherapy at Samsung Medical Center.

• Focused expertise in gynecological cancers and chemotherapy treatments
• Works at Samsung Medical Center, a leading healthcare institution
• Oncogynecologist with a strong background in women's cancer care

Prof. Elke Jaeger is one of Germany's top oncologists according to Focus rating, specializing in sarcoma treatment at Nordwest Clinic.

• 41 years of experience of experience in oncology and hematology
• Head of Oncology and Hematology at Nordwest Clinic
• Recognized as a top sarcoma specialist

Dr. Ahmet Bilici is a renowned medical oncologist specializing in sarcoma and lung cancer with over 28 years of experience of experience.

• One of the best sarcoma and lung cancer doctors in Turkey
• Extensive expertise in oncology treatment
• Practices at Medipol Mega University Hospital

Associate Professor of Hematology with 50+ publications – Dr. Eren is a specialist in hematologic oncology at Biruni University Hospital.

• Expert in chemotherapy for hematologic malignancies
• Member of European Society of Hematology
• Winner of multiple research awards in hematology
• Speaks English fluently

Prof. Paksoy brings extensive expertise in chemotherapy, backed by his role as Medical Oncology Assoc. Prof. at Medipol Bahçelievler Hospital.

• ESMO Board Certified in Medical Oncology
• Participated in 8 international clinical trials
• Published multiple peer-reviewed studies on chemotherapy outcomes
• Fellowship-trained at Istanbul University Oncology Institute

Dr. Apak specializes in pediatric hematology-oncology with 26 years of experience of experience, including bone marrow transplantation and CAR T-cell therapy at Biruni University Hospital.

• Head of Pediatric Hematology-Oncology Division at Istanbul University-Cerrahpaşa
• Authored 75 international publications in pediatric oncology
• Assistant editor for Turkish Pediatrics Archives Periodical
• Board member of Turkish Pediatric Society and Turkish Adolescent Association